Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease | Zendy

William F. Fearon | Zendy; Bernhard Bornschein | Zendy; Pim A.L. Tonino | Zendy; Raffaella Matteucci Gothe | Zendy; Bernard De Bruyne | Zendy; Nico H.J. Pijls | Zendy; Uwe Siebert | Zendy

Open Access

Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

Author(s) -

William F. Fearon,

Bernhard Bornschein,

Pim A.L. Tonino,

Raffaella Matteucci Gothe,

Bernard De Bruyne,

Nico H.J. Pijls,

Uwe Siebert

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.925396

Subject(s) - medicine , fractional flow reserve , percutaneous coronary intervention , quality of life (healthcare) , confidence interval , coronary artery disease , quality adjusted life year , cost effectiveness , percutaneous , cardiology , emergency medicine , coronary angiography , myocardial infarction , risk analysis (engineering) , nursing

The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) study demonstrated significantly improved health outcomes at 1 year in patients randomized to multivessel percutaneous coronary intervention guided by fractional flow reserve (FFR) compared with percutaneous coronary intervention guided by angiography alone. The economic impact of routine measurement of FFR in this setting is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research